Latest Projects and Scientific Studies
TEMPO 2 Study New
To demonstrate the efficacy of using TNK-tPA to treat minor ischemic stroke in proven arterial occlusion.
A Phase 3, prospective, randomized controlled, open-‐label with blinded outcome assessment (PROBE) controlled trial.
ESCAPE NA-1
To determine the efficacy of the neuroprotctant NA-1 in reducing global disavility in subjects with AIS with a small establisehd infarct core and good collateral circulation selected for EVT.
IDEF (NIH-NINDS) Free
The focus of this study is to evaluate the investigational drug, deferoxamine mesylate or deferoxamine. This drug removes iron. Blood in the brain after a brain hemorrhage contains iron and this iron damages the brain. We are studying whether removal of iron from the brain hemorrhage will reduce the effects of the brain hemorrhage. We will look specifically at a person’s ability to function well and to think well after a brain hemorrhage. We will also learn more about the safety of the investigational drug.
